Literature DB >> 16872708

PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells.

Sukmi Kang-Park1, Jee H Im, Je H Lee, Young I Lee.   

Abstract

PTEN gene, a novel tumor suppressor is frequently mutated or deleted in several malignancies including human hepatocellular carcinoma (HCC). We report previously that human hepatitis B virus-X (HBx) protein achieves protection from apoptotic cell death through-PI3K-Akt-Bad signaling that is p53-independent in liver cells (JBC; 276, 16969 (2000)). In this report, we demonstrated the PTEN effect on HBx induced anti-apoptotic signaling in Chang liver cells (CHL). Expression of PTEN in CHL cells downregulate HBx induced PI3K, Akt activities, Akt, Bad phosphorylations, decreased caspase 3 activity and protection from DNA fragmentations. PTEN suppression of CHL cell growth at G1 phase (JBC;278,4057(2003)) in cell cycle analysis, which is overcome by HBx activated Akt/PKB further confirmed that same PI3K/Akt pathway is involved in cell survival and apoptosis by HBx and PTEN. PTEN suppression of HBx-mediated cell survival through PI3K pathway is specific, since PTEN does not suppress the effect of HBx on the protection from Fas-mediated apoptosis. Taken together, these findings demonstrate that PTEN potently modulate HBx-mediated signaling and is a viable target in therapeutic approaches to inhibit the formation of HCC caused by HBV infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872708     DOI: 10.1016/j.virusres.2006.06.010

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

2.  Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection.

Authors:  Ebrahim Eskandari; Tayebeh Dahmardeh; Fatemeh Dahmardeh; Elham Pahlevani; Malihe Metanat
Journal:  Virusdisease       Date:  2017-08-22

3.  Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB.

Authors:  Yong Zhang; Rong-Qing Li; Xu-Dong Feng; Yan-Hua Zhang; Li Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 4.  Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.

Authors:  Linda S Steelman; William H Chappell; Stephen L Abrams; Ruth C Kempf; Jacquelyn Long; Piotr Laidler; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Franca Stivala; Maria C Mazzarino; Marco Donia; Paolo Fagone; Graziella Malaponte; Ferdinando Nicoletti; Massimo Libra; Michele Milella; Agostino Tafuri; Antonio Bonati; Jörg Bäsecke; Lucio Cocco; Camilla Evangelisti; Alberto M Martelli; Giuseppe Montalto; Melchiorre Cervello; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

Review 5.  Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.

Authors:  Melchiorre Cervello; James A McCubrey; Antonella Cusimano; Nadia Lampiasi; Antonina Azzolina; Giuseppe Montalto
Journal:  Oncotarget       Date:  2012-03

6.  Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.

Authors:  Mingyue Zhu; Junli Guo; Wei Li; Yan Lu; Shigan Fu; Xieju Xie; Hua Xia; Xu Dong; Yi Chen; Ming Quan; Shaojiang Zheng; Keping Xie; Mengsen Li
Journal:  Oncotarget       Date:  2015-05-20

7.  HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells.

Authors:  Mingyue Zhu; Junli Guo; Wei Li; Hua Xia; Yan Lu; Xu Dong; Yi Chen; Xieju Xie; Shigan Fu; Mengsen Li
Journal:  BMC Cancer       Date:  2015-05-06       Impact factor: 4.430

8.  Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations on the risk of hepatocellular carcinoma.

Authors:  Yan Du; Yu-Wei Zhang; Rui Pu; Xue Han; Jian-Ping Hu; Hong-Wei Zhang; Hong-Yang Wang; Guang-Wen Cao
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

Review 9.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

Review 10.  Modulation of apoptotic signaling by the hepatitis B virus X protein.

Authors:  Siddhartha Rawat; Amy J Clippinger; Michael J Bouchard
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.